AI assistant
Sending…
Cardiff Oncology, Inc. — Director's Dealing 2021
Mar 29, 2021
33967_dirs_2021-03-29_8d0d32e2-8a53-4d28-a71a-c709e22fa0b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardiff Oncology, Inc. (CRDF)
CIK: 0001213037
Period of Report: 2021-03-26
Reporting Person: Markin Rodney S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-26 | Common Stock | P | 2900 | $10.3218 | Acquired | 23879 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7181 | Direct |
Footnotes
F1: Through Prairie Ventures, LLC
More from Cardiff Oncology, Inc.
Investor Presentation
2026
Jun 3
Legal Proceedings Report
2026
May 29
Legal Proceedings Report
2026
May 19
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 14
Board/Management Information
2026
Apr 9
Investor Presentation
2026
Feb 25
Earnings Release
2026
Feb 24
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 18